Shares of AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) have earned a consensus recommendation of “Buy” from the four research firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued ratings on the stock in […]